Doubts About Moderna’s Virus Vaccine Halts Rally

May.20 — Moderna shares are falling from an all-time high after investors digested a report questioning early data from a small trial of its potential coronavirus vaccine. The biotech company closed down 10% after Monday’s 20% gain. The gradual slide began when a report highlighted the early nature of the vaccine data. Bloomberg’s Annmarie Hordern reports on “Bloomberg Daybreak: Europe.”

Watch the video at Bloomberg – Corona Outbreak